← All 10x Genomics, INC filings

10x Genomics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
TXG
10x Genomics, INC
DEF: 10x Genomics 2026 Proxy Statement Overview
10x Genomics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 4, 2026.
NASDAQ
TXG
10x Genomics, INC
DEFA14A: 10x Genomics, Inc. Files Definitive Proxy Statement
10x Genomics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
TXG
10x Genomics, INC
DEF: 10x Genomics Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
10x Genomics will hold its 2025 Annual Meeting of Stockholders virtually on June 3, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
TXG
10x Genomics, INC
DEFA14A: 10x Genomics Seeks Bylaw Amendment to Streamline Governance, Align with Industry Standards
10x Genomics is seeking shareholder approval to amend its bylaws, allowing the Board to make changes without requiring a shareholder vote, a practice aligned with the vast majority of public companies.
NASDAQ
TXG
10x Genomics, INC
DEFA14A: 10x Genomics Files Definitive Proxy Statement
10x Genomics has filed a definitive proxy statement with the SEC.
NASDAQ
TXG
10x Genomics, INC
DEF 14A: 10x Genomics Sets Date for 2024 Annual Stockholders Meeting, Proposes Bylaw Amendment
10x Genomics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 11, 2024, including proposals for director election, auditor ratification, bylaw amendment, and executive compensation advisory vote.